Actively Recruiting
Optimization of Percutaenous Coronary Intervention With Liberal Use of Post-dilatation
Led by Cathreine BV · Updated on 2025-08-07
12000
Participants Needed
1
Research Sites
139 weeks
Total Duration
On this page
Sponsors
C
Cathreine BV
Lead Sponsor
M
Medtronic
Collaborating Sponsor
AI-Summary
What this Trial Is About
To achieve optimal long-term clinical results after percutaneous coronary intervention (PCI), adequate deployment of stents is essential. Thorough expansion of the stent and full apposition of stent struts against the vessel wall are determining factors for preventing stent thrombosis and restenosis for bare-metal as well as drug-eluting stents (DES). Standard coronary angiography is limited in assessing accurate vessel size and characterizing tissues and calcium load. Therefore, stent underexpansion frequently occurs after stent deployment. Post-dilation is often performed to achieve optimal stent expansion and reduce stent malapposition of stent struts, aiming to reduce stent thrombosis and restenosis both short term as long term. However, there are limited studies that have explored the effect of post-dilatation for stent optimization on clinical outcomes. As a result of the restricted evidence, there is no consensus whether post-dilatation should be used routinely in clinical practice and the extent to which post-dilatation is being utilized remains unclear. For this reason, the OPTIMIZE PCI was designed, a national registry-based quality improvement project to implement a liberal post-dilatation strategy in multiple PCI centers in the Netherlands. As part of the OPTIMIZE-PCI, a retrospective observational analysis will eventually be conducted to evaluate whether adopting this strategy has led to improved clinical outcomes after PCI in terms of major adverse cardiac events.
CONDITIONS
Official Title
Optimization of Percutaenous Coronary Intervention With Liberal Use of Post-dilatation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- All patients older than 18 years who undergo PCI for any reason are included in the Netherlands Heart Registration and in the study analysis
You will not qualify if you...
- Only the first PCI procedure is included if a patient has multiple PCIs within 365 days
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Catharina Hospital
Eindhoven, North Brabant, Netherlands, 5623 EJ
Actively Recruiting
Research Team
K
K Teeuwen, MD, PhD
CONTACT
K
K.A.J. Beek, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here